scispace - formally typeset
Search or ask a question
Topic

Addiction medicine

About: Addiction medicine is a research topic. Over the lifetime, 1070 publications have been published within this topic receiving 23685 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: In health systems without access to addiction medicine experts, infectious diseases providers, hospitalists, and other clinicians serve a valuable role in the diagnosis and treatment of OUD.

3 citations

Journal ArticleDOI
TL;DR: Research publications in psychiatry and addiction medicine have a low level of evidence and the most vulnerable were the characteristics which were the most important for evidence.
Abstract: AIM To evaluate the quality of research articles in psychiatry and addiction medicine published in 2015. MATERIAL AND METHODS Five experts analyzed 51 research publications from 13 psychiatric and addiction medicine journals using a standardized questionnaire, which contains 4 general questions (type or results of the study) and 21 questions on the quality of the study. RESULTS Only 2 articles (4%) met all criteria, 64% of the articles refer to the methodologically least demonstrative (uncontrolled/one-time, series of cases, non-randomized). The most vulnerable were the characteristics which were the most important for evidence: a description of the methods, statistical analysis, accounting for systematic errors and/or side effects, the distribution of patients by group. CONCLUSION Research publications in psychiatry and addiction medicine have a low level of evidence.

3 citations

Journal ArticleDOI
TL;DR: In this article, the authors review clinical care issues that are related to illicit and therapeutic opioid use among pregnant women and women in the postpartum period and outline the major responsibilities of obstetrics providers who care for these patients during the antepartum, intrapartum and post-partum periods.
Abstract: We review clinical care issues that are related to illicit and therapeutic opioid use among pregnant women and women in the postpartum period and outline the major responsibilities of obstetrics providers who care for these patients during the antepartum, intrapartum, and postpartum periods. Selected patient treatment issues are highlighted, and case examples are provided. Securing a strong rapport and trust with these patients is crucial for success in delivering high-quality obstetric care and in coordinating services with other specialists as needed. Obstetrics providers have an ethical obligation to screen, assess, and provide brief interventions and referral to specialized treatment for patients with drug use disorders. Opioid-dependent pregnant women often can be treated effectively with methadone or buprenorphine. These medications are classified as pregnancy category C medications by the Food and Drug Administration, and their use in the treatment of opioid-dependent pregnant patients should not be considered "off-label." Except in rare special circumstances, medication-assisted withdrawal during pregnancy should be discouraged because of a high relapse rate. Acute pain management in this population deserves special consideration because patients who use opioids can be hypersensitive to pain and because the use of mixed opioid-agonist/antagonists can precipitate opioid withdrawal. In the absence of other indications, pregnant women who use opioids do not require more intense medical care than other pregnant patients to ensure adequate treatment and the best possible outcomes. Together with specialists in pain and addiction medicine, obstetricians can coordinate comprehensive care for pregnant women who use opioids and women who use opioids in the postpartum period.

3 citations

Journal ArticleDOI
TL;DR: This workshop was intended to prepare psychiatry residents to understand the complex demands of southwest Virginia's patient population, given the region's higher risk for opioid dependence.
Abstract: The most commonly abused substances in southwest Virginia are prescription medications. One of the most significant trends in Virginia is the percent of the population aged 12 and older using pain relievers for nonmedical purposes. Although the rate for the state as a whole (4.42%) is less than the national rate (4.89%), the southwest Virginia regional rate of 5.51% exceeds the national rate.1 The American Academy of Addiction Psychiatry, the American Osteopathic Academy of Addiction Medicine, and the American Psychiatric Association have been awarded a 3-year grant by the Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Treatment to operate the Physicians' Clinical Support System for Buprenorphine (PCSS-B), effective July 1, 2011.2 This initiative provides training and clinical mentorship to practicing physicians and physicians-in-training who wish to include office-based treatment of opioid use disorders in their practices.2 The state of Virginia has 5 general psychiatry residency programs, of which Carilion Clinic–Virginia Tech Carilion Psychiatry Residency Program (CC-VTCSOM) may be the first to teach their general psychiatry residents about office-based treatment of opioid dependence by using this initiative. The program coordinates PCSS-B training for 17 of CC-VTCSOM's 32 psychiatry residents. The size of the training group was capped at 20, and 3 members of the faculty took the training as well. Residents and faculty completed a 3.75-hour training course, according to guidelines from PCSS-B, followed by a 4.25-hour face-to-face session by board- certified addiction psychiatrists, which included the program director for the addictions fellowship at CC-VTCSOM. This session included an interactive component with clinical case vignettes. Topics included an overview of office-based treatment of substance use disorders, review of opioids, introduction to buprenorphine/naloxone, special aspects of treatment of substance abuse disorders, and use of buprenorphine in special patient populations. This workshop was intended to prepare psychiatry residents to understand the complex demands of southwest Virginia's patient population, given the region's higher risk for opioid dependence.

3 citations


Network Information
Related Topics (5)
Mental health
183.7K papers, 4.3M citations
82% related
Psychosocial
66.7K papers, 2M citations
78% related
Psychological intervention
82.6K papers, 2.6M citations
77% related
Anxiety
141.1K papers, 4.7M citations
77% related
Public health
158.3K papers, 3.9M citations
76% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
202324
202251
202175
202065
201946
201827